Skip to main content

Table 1 Characteristics of study participants

From: New evidences on the altered gut microbiota in autism spectrum disorders

 

Autistic

Neurotypical

Subjects (n)

40

40

Age (1st–3rd quartile)

10 (5–17)

7 (3.6–12)

Gender (n)

 Female

22.5% (9)

30% (12)

 Male

77.5% (31)

70% (28)

Constipation (n)

 Constipated

12.5% (5)

27.5% (11)

 Non-constipated

72.5% (29)

72.5% (29)

 NA

15% (6)

0% (0)

Calprotectin (1st–3rd quartile)

36.9 (17.6–76.0) μg/g

40.9 (17–74.7) μg/g

 Constipated

39.1 (22.9–70.0) μg/g

27.9 (20.3–97.6) μg/g

 Non-constipated

35.9 (15.0–57.8) μg/g

50.5 (15.0–73.8) μg/g

CARS (1st–3rd quartile)

47 (40–50.5)

NA

 Constipated

50 (36–52.0)

NA

 Non-constipated

48 (42–50.0)

NA

ESR (1st–3rd quartile)

7.5 (3.25–17.7) mm/h

NA

 Constipated

22.0 (12.0–25.0) mm/h

NA

 Non-constipated

7.0 (2.7–11.2) mm/h

NA

Serum IgA (1st–3rd quartile)

131.0 (70.0–172.2) mg/ml

NA

 Constipated

97.0 (82.0–153.0) mg/ml

NA

 Non-constipated

133.0 (67.0–181.0) mg/ml

NA

  1. Data expressed as medians with interquartile ranges when applicable. AD autistic subjects, NT neurotypical subjects, NA not applicable, CARS Childhood Autism Rating Scale, ESR erythrocyte sedimentation rate